BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$323M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$345M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$305M |
| 4 |
PPLI
People Inc
PPLI
|
+$203M |
| 5 |
Visa
V
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12% |
| 2 | Consumer Discretionary | 7.3% |
| 3 | Healthcare | 5.39% |
| 4 | Financials | 5.24% |
| 5 | Communication Services | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
UMB Financial
UMBF
$11.5B
| $379K | ﹤0.01% |
7,743
-8,404
| -52% | -$424K |
|
2252
Acadia Healthcare
ACHC
$2.87B
| $379K | ﹤0.01% |
12,847
+7,586
| +144% | +$220K |
|
2253
NMI Holdings
NMIH
$3.44B
| $377K | ﹤0.01% |
21,174
+16,774
| +381% | +$274K |
|
2254
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $374K | ﹤0.01% |
+103
| New | +$3.87K |
|
2255
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
| $374K | ﹤0.01% |
6,900
| – | – |
|
|
RVNC
2256
DELISTED
Revance Therapeutics, Inc.
RVNC
| $374K | ﹤0.01% |
14,879
+12,526
| +532% | +$328K |
|
|
AIMT
2257
DELISTED
Aimmune Therapeutics
AIMT
| $374K | ﹤0.01% |
10,850
+1,172
| +12% | +$25K |
|
2258
CryoPort
CYRX
$772M
| $373K | ﹤0.01% |
7,877
+6,576
| +505% | +$266K |
|
|
EMBJ
2259
Embraer S.A. ADS
EMBJ
$13.4B
| $372K | ﹤0.01% |
84,421
+22,026
| +35% | +$122K |
|
2260
Harmony Gold Mining
HMY
$12.1B
| $372K | ﹤0.01% |
70,640
+635
| +0.9% | +$3.79K |
|
2261
PUT
Zions Bancorporation
ZION
$10.5B
| $371K | ﹤0.01% |
127
| – | – |
|
2262
RLJ Lodging Trust
RLJ
$1.67B
| $371K | ﹤0.01% |
42,799
-28,685
| -40% | -$257K |
|
|
CIM
2263
Chimera Investment
CIM
$988M
| $371K | ﹤0.01% |
15,062
+6,853
| +83% | +$183K |
|
|
SMAR
2264
DELISTED
Smartsheet Inc.
SMAR
| $369K | ﹤0.01% |
7,464
-2,467
| -25% | -$119K |
|
|
VRTU
2265
DELISTED
Virtusa Corporation
VRTU
| $369K | ﹤0.01% |
7,503
+5,335
| +246% | +$212K |
|
2266
Federated Hermes
FHI
$4.79B
| $368K | ﹤0.01% |
17,117
+5,295
| +45% | +$126K |
|
2267
Interface
TILE
$2.19B
| $368K | ﹤0.01% |
60,160
+9,825
| +20% | +$73.3K |
|
2268
Grocery Outlet
GO
$1.1B
| $366K | ﹤0.01% |
9,310
+6,242
| +203% | +$257K |
|
|
LTHM
2269
DELISTED
Livent Corporation
LTHM
| $365K | ﹤0.01% |
40,736
+26,944
| +195% | +$203K |
|
2270
Central Garden & Pet Co Class A
CENTA
$2.37B
| $365K | ﹤0.01% |
12,623
+8,418
| +200% | +$242K |
|
2271
Cytokinetics
CYTK
$10.3B
| $365K | ﹤0.01% |
16,844
+10,410
| +162% | +$244K |
|
|
AXNX
2272
DELISTED
Axonics, Inc. Common Stock
AXNX
| $364K | ﹤0.01% |
7,139
+5,915
| +483% | +$247K |
|
2273
Jack in the Box
JACK
$325M
| $364K | ﹤0.01% |
4,593
-836
| -15% | -$67.3K |
|
2274
La-Z-Boy
LZB
$1.67B
| $364K | ﹤0.01% |
11,516
+7,509
| +187% | +$228K |
|
|
VISN
2275
Vistance Networks Inc
VISN
$2.66B
| $364K | ﹤0.01% |
40,450
-431,277
| -91% | -$4.06M |
|
Similar funds
BNP Paribas Financial Markets's Q3 2020 Portfolio in Review
As of Q3 2020, BNP Paribas Financial Markets held 4,385 positions worth $69.9B, up 23% from $56.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $2.99B of net new capital in Q3 2020, opening 85 new positions and adding to 2,667 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $345M trimmed.
- BNP Paribas Financial Markets's largest Q3 2020 buy was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q3 2020, an estimated $1.93B increase.
- BNP Paribas Financial Markets's biggest Q3 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $345M.
- BNP Paribas Financial Markets fully exited People Inc in Q3 2020, selling an estimated $203M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $69.9B portfolio in Q3 2020.
- BNP Paribas Financial Markets opened 85 new positions and closed 175 in Q3 2020.
- BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $69.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.